STRATA Skin Sciences to Present at Upcoming October Conferences
HORSHAM, Pa. , Sept. 27, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will be presenting at
STRATA Skin Sciences to Host Virtual KOL Event on XTRAC® and TheraClear®X
HORSHAM, Pa. , Aug. 24, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it will host a virtual key opinion leader
STRATA Skin Sciences Reports Second Quarter 2023 Revenue
Company to Host Conference Call and Webcast Today, August 9, 2023, at 4:30 PM ET HORSHAM, Pa. , Aug. 09, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of
STRATA Skin Sciences to Participate in Upcoming August Conferences
HORSHAM, Pa. , Aug. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will be participating in
STRATA Skin Sciences to Report Second Quarter 2023 Financial Results on August 9, 2023
HORSHAM, Pa. , July 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second
STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris
HORSHAM, Pa. , July 11, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Journal of Clinical and Aesthetic
STRATA Skin Sciences Secures additional $12 Million Financing with MidCap Financial
HORSHAM, Pa. , July 06, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it has completed the refinancing of
STRATA Skin Sciences Appoints Dr. Uri Geiger to Chairman of its Board of Directors
HORSHAM, Pa. , June 30, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the appointment of Dr.
STRATA Skin Sciences Announces First Patients Treated in TheraClear®X Clinical Study for Acne
Study evaluating efficacy and safety of TheraClearX on mitigating mild to moderate acne in healthy teenagers and young adults HORSHAM, Pa. , May 30, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and
STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Music City Scale Symposium for Cosmetic Advances and Laser Education
HORSHAM, Pa. , May 19, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced Joel L.